#sanofi — Public Fediverse posts

Sanofi (ENXTPA:SAN) Ends Amlitelimab Development For Atopic Dermatitis After Pipeline Review

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#France #FR #Europe #EU #Sanofi #developmentpriorities #SimplyWallSt
https://www.europesays.com/france/60456/

Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
#France #FR #Europe #EU #Sanofi #BristolMyers #initialassessment #RegeneronPharmaceuticals
https://www.europesays.com/france/60085/

Press Release: Sanofi’s half-year financial report for 2026

Sanofi Winthrop Industrie  Sanofi’s half-year financial report for 2026 Paris, July 30, 2026. Sanofi announces that its half-year…
#France #FR #Europe #EU #Sanofi #Autoritédesmarchésfinanciers #FinancialReport
https://www.europesays.com/france/60078/

Sanofi abandons eczema drug approval efforts in another blow to OX40 class

Sanofi has chosen not to file for approval or continue the development of its immunology therapy, amlitelimab, in…
#France #FR #Europe #EU #Sanofi #AD #blockbusterdrug #development #developmentprogramme #discontinuation #drugclass #GlobalData #marketprospects #TanujSircar
https://www.europesays.com/france/59964/

Sanofi (Nasdaq: SNY) Raises 2026 Sales Guidance

Sanofi raised its 2026 sales guidance after Q2 net sales rose 17.8% at constant exchange rates, led by…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/59812/

Sanofi lifts 2026 outlook after strong Q2 growth | SNY SEC Filing

Washington, D.C. 20549 Indicate by check mark whether the registrant files or will file annual reports under cover…
#France #FR #Europe #EU #Sanofi #2026guidance #biopharma #businessEPS #Dupixentsales #FreeCashFlow #pharmaearnings #quarterlyresults #SNY #vaccines
https://www.europesays.com/france/59683/

Sanofi grows H1 2026 sales, earnings decline | SNY SEC Filing

Washington, D.C. 20549 Indicate by check mark whether the registrant files or will file annual reports under cover…
#France #FR #Europe #EU #Sanofi #amlitelimabimpairment #Dynavaxacquisition #Form6-K #half-year2026results #netdebt15.5B #netsales22.1B #Pharmaceuticals #SNY
https://www.europesays.com/france/59677/

Sanofi heavily punished despite strong results and a raised target

Sanofi posted the steepest decline in the CAC 40 (-7.52%, to €73.87), despite a solid financial performance in…
#France #FR #Europe #EU #Sanofi #Markets
https://www.europesays.com/france/59667/

Sanofi Q2 Earnings Call Highlights

Key Points Interested in Sanofi? Here are five stocks we like better. Sanofi raised its 2026 outlook after…
#France #FR #Europe #EU #Sanofi #Dupixent
https://www.europesays.com/france/59655/

Press Release: Sanofi’s half-year financial report for 2026

Sanofi Winthrop Industrie  Sanofi’s half-year financial report for 2026 Paris, July 30, 2026. Sanofi announces that its half-year…
#France #FR #Europe #EU #Sanofi #Autoritédesmarchésfinanciers #FinancialReport
https://www.europesays.com/france/59644/

Why Sanofi Stock Is Falling Thursday – Sanofi (NASDAQ:SNY)

Dupixent Drives Growth While Vaccines Sales Decline Dupixent sales increased by 37.6% to 5.154 billion euros, above 5…
#France #FR #Europe #EU #Sanofi #category:Biotech #category:Earnings #category:General #category:Guidance #category:HealthCare #category:LargeCap #category:Movers #category:News #category:TopStories #CMS:WordPress #PageIsBzPro:BZ #symbol:SNY #tag:whyit'smoving
https://www.europesays.com/france/59466/

Sanofi Increases Sales Outlook Driven by Dupixent Success Under New CEO, ETPharma

London: Sanofi raised its full-year sales ​forecast on Thursday, on the back of strong demand ​for blockbuster asthma…
#France #FR #Europe #EU #Sanofi #BelenGarijoCEO #Dupixentsalesgrowth #Sanofidrugdevelopment #Sanofirevenueincrease #Sanofisalesforecast
https://www.europesays.com/france/59451/

Regeneron beats quarterly estimates on eczema drug strength, shares rise | WKZO | Everything Kalamazoo

July 30 (Reuters) – Regeneron on Thursday beat Wall Street estimates for second-quarter revenue and profit, helped by…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/59433/

Sanofi Beats on Q2 Earnings & Sales, Stock Down on Pipeline Setbacks

Sanofi SNY reported second-quarter 2026 adjusted earnings of $1.22 per American depositary share, which comfortably beat the Zacks…
#France #FR #Europe #EU #Sanofi #Americandepositaryshare #CER #DupixentSalesCross #globalsales #QuarterlySales #ZacksConsensusEstimate
https://www.europesays.com/france/59418/

Sanofi drops two more programmes in R&D clear-out

Shortly after terminating one late-stage R&D programme, Sanofi has confirmed two others are being abandoned as part of…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/59399/

Sanofi lifts 2026 outlook as dupilumab tops €5bn

Sanofi has upgraded its full-year 2026 guidance after reporting strong second-quarter sales growth, driven by continued demand for…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/59381/

Sanofi Slides After Q2 as Investors Focus on Pipeline Cuts Despite Higher 2026 Outlook

Sanofi (SNY) is down 6.8% today. Here is some analysis on what might have caused this price movement.…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/59362/

Sanofi Beats on Q2 Earnings & Sales, Stock Down on Pipeline Setbacks – July 30, 2026

Key Takeaways Sanofi beat Q2 earnings and sales estimates as Dupixent once again drove sales growth. SNY raised…
#France #FR #Europe #EU #Sanofi #Financial #FinancialPlanning #Investing #Investment #investmentadvice #onlineinvestment #onlinestocktrading #onlinetrading #quote #quotes #stock #stockmarket #stockquotes #stocks
https://www.europesays.com/france/59341/

Press Release: Sanofi’s half-year financial report for

Sanofi’s half-year financial report for 2026 Paris, July 30, 2026. Sanofi announces that its half-year financial report for…
#France #FR #Europe #EU #Sanofi #ParisStockExchange:SAN #SanofiWinthropIndustrie
https://www.europesays.com/france/59320/

Press Release: Sanofi’s half-year financial report for 2026

Sanofi’s half-year financial report for 2026 Paris, July 30, 2026. Sanofi announces that its half-year financial report for…
#France #FR #Europe #EU #Sanofi #2026 #Financial #for #Half-year #press #release #report #Sanofi’s
https://www.europesays.com/france/59303/

Sanofi axes two more inflammatory-disease drugs

Why it matters: The decisions remove two externally sourced drugs from Sanofi’s immunology pipeline, days after the French…
#France #FR #Europe #EU #Sanofi #ClinicalData
https://www.europesays.com/france/59281/

Sanofi’s Dupixent Outlook Improved, But Investors Wanted More

ally arrives. That’s why the pipeline decisions landed poorly. Sanofi discontinued amlitelimab – tied to the impairment –…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/59260/

Regeneron beats quarterly estimates on eczema drug strength, shares rise

July 30 (Reuters) – Regeneron on Thursday beat Wall Street estimates for second-quarter revenue and profit, helped by…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/59240/

Sanofi’s new CEO wants more ‘realistic view’ of Phase 3 go/no-go decisions

Sanofi will be more judicious in moving assets into late-stage development under new CEO Belén Garijo, first making…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/59222/

Sanofi steps up in the second quarter thanks to Dupixent and its new treatments

The drugmaker posted strong growth in both activity and profitability in the second quarter of 2026, driven by…
#France #FR #Europe #EU #Sanofi #Markets
https://www.europesays.com/france/59110/

Sanofi raises sales outlook on Dupixent strength in boost for new CEO

By Bhanvi Satija LONDON, July 30 (Reuters) – Sanofi on Thursday raised its full-year sales forecast ‌on the…
#France #FR #Europe #EU #Sanofi #CEOBelenGarijo
https://www.europesays.com/france/59088/

Sanofi raises sales outlook on Dupixent strength in boost for new CEO | The Mighty 790 KFGO

By Bhanvi Satija LONDON, July 30 (Reuters) – Sanofi raised its full-year sales forecast on Thursday, on the…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/59068/

Sanofi raises sales outlook on Dupixent strength in boost for new CEO

By Bhanvi Satija LONDON, July 30 (Reuters) – Sanofi raised its full-year sales forecast on Thursday, on the…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/59052/

Why Lantus insulin is in short supply in Connecticut

Thousands of Connecticut patients who rely on certain types of insulin are facing intermittent shortages caused by surging…
#France #FR #Europe #EU #Sanofi #alldailysites
https://www.europesays.com/france/58870/

Sanofi Consumer Healthcare Q1FY27 Profit Jumps 13.3% to ₹68.8 Crore, Revenue Up 6.7% on Margin Expansion

Sanofi Consumer Healthcare India reported a 13.3% year-on-year increase in net profit for the quarter…
#France #FR #Europe #EU #Sanofi #consumerhealthcare #domesticdemand #earningspershare #EBITDAmargin #Indiabusiness #marketshare #netprofit #NSEstock #precautionaryrecall #productrelaunch #profitgrowth #Q1results #Q1FY27 #revenuegrowth #SanofiConsumer
https://www.europesays.com/france/58105/

Sanofi (ENXTPA:SAN) Wins Two Drug Approvals In Japan And The EU

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide. Sanofi secured approval in Japan for Wayrilz (rilzabrutinib) to treat chronic immune thrombocytopenia. Cenrifki (tolebr…
#Japan #JP #JapanNews #immunethrombocytopenia #marketedproducts #news #Sanofi
https://www.alojapan.com/1502797/sanofi-enxtpasan-wins-two-drug-approvals-in-japan-and-the-eu/

https://www.alojapan.com/1502797/sanofi-enxtpasan-wins-two-drug-approvals-in-japan-and-the-eu/ Sanofi (ENXTPA:SAN) Wins Two Drug Approvals In Japan And The EU #ImmuneThrombocytopenia #Japan #JapanNews #MarketedProducts #news #Sanofi Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide. Sanofi secured approval in Japan for Wayrilz (rilzabrutinib) to treat chronic immune thrombocytopenia. Cenrifki (tolebrutinib) received EU approval for progressive mu

#news ⚡ Sanofi offen für moderate Erhöhung des Herstellerabschlags: Sanofi-Deutschlandchefin Heidrun Irschik-Hadjieff zeigt sich offen für eine moderate Erhöhung des Herstellerabschlags auf verschreibun... https://hubu.de/?p=331580 | #erhoehung #herstellerabschlags #sanofi #hubu

#news ⚡ Sanofi offen für moderate Erhöhung des Herstellerabschlags: Sanofi-Deutschlandchefin Heidrun Irschik-Hadjieff zeigt sich offen für eine moderate Erhöhung des Herstellerabschlags auf verschreibun... https://hubu.de/?p=331580 | #erhoehung #herstellerabschlags #sanofi #hubu

3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery

Some investors have watched their healthcare stock holdings drop in value recently or over the years, yet they…
#NewsBeep #News #Healthcare #AU #Australia #Bristol #Bristol-MyersSquibb #Health #Medtronic #Sanofi #stockholdings #stockprice
https://www.newsbeep.com/au/631162/

#Airbus, #BNP, #Sanofi, #Zara… #MoniqueBarbut https://fr.wikipedia.org/wiki/Monique_Barbut ministre de l’ #écologie, est actionnaire de dizaines de grandes entreprises

Le #média "Vert" a examiné la déclaration de l’ex-patronne du #WWF #France à la Haute autorité pour la transparence de la vie publique et a découvert plus de 150 000 € d’actions détenues dans 27 grandes entreprises, dont certaines au lourd bilan écologique. https://vert.eco/articles/airbus-bnp-sanofi-zara-monique-barbut-ministre-de-lecologie-est-actionnaire-de-dizaines-de-grandes-entreprises

#politique #info #information #actu #actualite

#Airbus, #BNP, #Sanofi, #Zara… #MoniqueBarbut https://fr.wikipedia.org/wiki/Monique_Barbut ministre de l’ #écologie, est actionnaire de dizaines de grandes entreprises

Le #média "Vert" a examiné la déclaration de l’ex-patronne du #WWF #France à la Haute autorité pour la transparence de la vie publique et a découvert plus de 150 000 € d’actions détenues dans 27 grandes entreprises, dont certaines au lourd bilan écologique. https://vert.eco/articles/airbus-bnp-sanofi-zara-monique-barbut-ministre-de-lecologie-est-actionnaire-de-dizaines-de-grandes-entreprises

#politique #info #information #actu #actualite

#Airbus, #BNP, #Sanofi, #Zara… #MoniqueBarbut https://fr.wikipedia.org/wiki/Monique_Barbut ministre de l’ #écologie, est actionnaire de dizaines de grandes entreprises

Le #média "Vert" a examiné la déclaration de l’ex-patronne du #WWF #France à la Haute autorité pour la transparence de la vie publique et a découvert plus de 150 000 € d’actions détenues dans 27 grandes entreprises, dont certaines au lourd bilan écologique. https://vert.eco/articles/airbus-bnp-sanofi-zara-monique-barbut-ministre-de-lecologie-est-actionnaire-de-dizaines-de-grandes-entreprises

#politique #info #information #actu #actualite

AI agenti mění fungování firem a organizací. A jak firmy v ČR využívají AI?
AzaNoviny - Techno
#ai #firmy #cesko #organizace #sanofi #osn
https://azanoviny.eu/2026/04/20/ai-agenti-meni-fungovani-firem-a-organizaci-a-jak-firmy-v-cr-vyuzivaji-ai/

AI agenti mění fungování firem a organizací. A jak firmy v ČR využívají AI?
AzaNoviny - Techno
#ai #firmy #cesko #organizace #sanofi #osn
https://azanoviny.eu/2026/04/20/ai-agenti-meni-fungovani-firem-a-organizaci-a-jak-firmy-v-cr-vyuzivaji-ai/

AI agenti mění fungování firem a organizací. A jak firmy v ČR využívají AI?
AzaNoviny - Techno
#ai #firmy #cesko #organizace #sanofi #osn
https://azanoviny.eu/2026/04/20/ai-agenti-meni-fungovani-firem-a-organizaci-a-jak-firmy-v-cr-vyuzivaji-ai/

AI agenti mění fungování firem a organizací. A jak firmy v ČR využívají AI?
AzaNoviny - Techno
#ai #firmy #cesko #organizace #sanofi #osn
https://azanoviny.eu/2026/04/20/ai-agenti-meni-fungovani-firem-a-organizaci-a-jak-firmy-v-cr-vyuzivaji-ai/

Global drug makers face pricing pressure as China targets affordable healthcare

Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #astrazeneca #Beijing #China #donaldtrump #EliLilly #Gardasil #Health #keytruda #Merck #Mounjaro #Roche #Sanofi #Washington
https://www.newsbeep.com/us/571163/

Sanofi ousts CEO after stalled turnaround at vaccine giant

French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant/

Sanofi ousts CEO after stalled turnaround at vaccine giant

French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant/

Sanofi ousts CEO after stalled turnaround at vaccine giant

French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant/

Sanofi ousts CEO after stalled turnaround at vaccine giant

French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant/

Sanofi ousts CEO after stalled turnaround at vaccine giant

French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant-2/

Sanofi ousts CEO after stalled turnaround at vaccine giant

French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant-2/

Sanofi ousts CEO after stalled turnaround at vaccine giant

French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant-2/

Sanofi ousts CEO after stalled turnaround at vaccine giant

French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…

https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant-2/

Sanofi hợp tác cùng Long Châu khởi động dự án “Thu gom & Tái chế nhựa từ vỉ thuốc vì tương lai xanh”, tập trung thu gom, xử lý và tái chế nhựa để giảm ô nhiễm và xây dựng thói quen bền vững trong cộng đồng. 🌱♻️

#Sanofi #LongChau #Sustainability #GreenFuture #ThuGom #TaiChe #PlasticRecycling #bảnvững #tươnglaixanh

https://vtcnews.vn/sanofi-va-long-chau-hop-luc-thuc-day-thoi-quen-song-ben-vung-trong-cong-dong-ar999451.html

Johnson & Johnson announces deal to cut drug prices, new Pennsylvania manufacturing site | Berks Regional News

NEW BRUNSWICK, Nj. – Johnson & Johnson is the latest U.S. drugmaker to announce …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #accesstomedicines #celltherapy #drugproductmanufacturingfacility #Health #joaquinduato #Johnson&Johnson #medicationcosts #MERCK&CO #Pennsylvania #Sanofi #TrumpAdministration #TrumpRx #trumprx.com
https://www.newsbeep.com/us/398424/

Sanofi kauft sich mit 2,56 Mrd. US-Dollar in die Zukunft der Medizin ein. Start-ups wie Earendil Labs wechseln von der bloßen Strukturvorhersage zur aktiven Konstruktion von Antikörpern mittels generativer KI. Parallel entwickelt das MIT KI-basierte Nanopartikel für die Krebsfrüherkennung. Die Ära des physischen Ausprobierens im Labor endet. Ist das der technologische Durchbruch oder ein gefährlicher Hype? #Sanofi #EarendilLabs #Pegasus
https://www.all-ai.de/news/news26/kuenstliche-antikoerper-sanofi

Sanofi kauft sich mit 2,56 Mrd. US-Dollar in die Zukunft der Medizin ein. Start-ups wie Earendil Labs wechseln von der bloßen Strukturvorhersage zur aktiven Konstruktion von Antikörpern mittels generativer KI. Parallel entwickelt das MIT KI-basierte Nanopartikel für die Krebsfrüherkennung. Die Ära des physischen Ausprobierens im Labor endet. Ist das der technologische Durchbruch oder ein gefährlicher Hype? #Sanofi #EarendilLabs #Pegasus
https://www.all-ai.de/news/news26/kuenstliche-antikoerper-sanofi

Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".

#MECFS #PAIS #Forschung

Zum Live-Stream: https://www.bundestag.de/mediathek/live

Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".

#MECFS #PAIS #Forschung

Zum Live-Stream: https://www.bundestag.de/mediathek/live

Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".

#MECFS #PAIS #Forschung

Zum Live-Stream: https://www.bundestag.de/mediathek/live

Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".

#MECFS #PAIS #Forschung

Zum Live-Stream: https://www.bundestag.de/mediathek/live

Impfmöglichkeit Booster Auffrischung 💉 #Sanofi #Novavax #Nuvaxovid #JN.1 #Biontech #Comirnaty #L.P.8.1 🏥 Reischmann Apotheke #Bahnstadt 📍Da-Vinci-Str. 7 69115 #Heidelberg #BaWü 📞 06221-24662 📧 [email protected] #COVID19 #CovidIsNotOver #TeamVorsicht #Impfung #impflp81 #nuvax25